248 related articles for article (PubMed ID: 16795934)
21. Medical devices; reclassification of six cardiovascular preamendments class III devices into class II. Final rule.
Food and Drug Administration
Fed Regist; 2001 Apr; 66(69):18540-2. PubMed ID: 11721689
[TBL] [Abstract][Full Text] [Related]
22. Medical devices; effective date of requirement for premarket approval for a class III preamendments obstetrical and gynecological device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jul; 65(129):41330-2. PubMed ID: 11067678
[TBL] [Abstract][Full Text] [Related]
23. Medical devices; general hospital and personal use devices; classification of the filtering facepiece respirator for use by the general public in public health medical emergencies. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Jul; 72(127):36360-3. PubMed ID: 17674487
[TBL] [Abstract][Full Text] [Related]
24. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686
[TBL] [Abstract][Full Text] [Related]
25. Medical devices; effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(120):34917-20. PubMed ID: 15224687
[TBL] [Abstract][Full Text] [Related]
26. Effect of the final rule on the conduct of emergency clinical research.
Gonzalez SK; Helling TS
J Trauma; 2008 Jun; 64(6):1665-72. PubMed ID: 18545136
[TBL] [Abstract][Full Text] [Related]
27. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments.
Department of Health and Human Services (HHS)
Fed Regist; 2005 Feb; 70(22):5543-65. PubMed ID: 15690579
[TBL] [Abstract][Full Text] [Related]
28. Medical devices; designation of special control for eight surgical suture devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(106):32983-5. PubMed ID: 12784826
[TBL] [Abstract][Full Text] [Related]
29. Informed consent elements. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jan; 76(2):256-70. PubMed ID: 21261126
[TBL] [Abstract][Full Text] [Related]
30. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
31. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
[TBL] [Abstract][Full Text] [Related]
32. Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research?
Nichol G; Huszti E; Rokosh J; Dumbrell A; McGowan J; Becker L
Resuscitation; 2004 Jul; 62(1):3-23. PubMed ID: 15246579
[TBL] [Abstract][Full Text] [Related]
33. Introduction to the Food and Drug Administration (FDA) regulatory process.
Hackett JL; Gutman SI
J Proteome Res; 2005; 4(4):1110-3. PubMed ID: 16083260
[TBL] [Abstract][Full Text] [Related]
34. First FDA medical device regulations will affect development of many experimental contraceptives.
Fam Plann Perspect; 1980; 12(4):212-3. PubMed ID: 7439345
[TBL] [Abstract][Full Text] [Related]
35. Medical: informed consent--designate health care professionals to obtain informed consent. Final rule.
Department of Veterans Affairs
Fed Regist; 2007 Mar; 72(45):10365-7. PubMed ID: 17450650
[TBL] [Abstract][Full Text] [Related]
36. Medical devices; apnea monitor; special controls. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jul; 67(137):46851-2. PubMed ID: 12125715
[TBL] [Abstract][Full Text] [Related]
37. Public information; communications with state and foreign government officials--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(143):40069-72. PubMed ID: 10181518
[TBL] [Abstract][Full Text] [Related]
38. Investigational new drug applications; amendment to clinical hold regulations for products intended for life-threatening diseases and conditions. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jun; 65(106):34963-71. PubMed ID: 11010726
[TBL] [Abstract][Full Text] [Related]
39. Protection of human subjects; informed consent; correction. Food and Drug Administration. Final rule; correction.
Fed Regist; 1982 Feb; 47(31):6617-8. PubMed ID: 10298463
[TBL] [Abstract][Full Text] [Related]
40. When informed consent is not required in studies.
Maloney DM
Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
